Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin gamma-2 chain (TUBG2) is a less common γ-tubulin isoform in vertebrates, part of the highly conserved tubulin family essential for initiating microtubule nucleation. γ-Tubulins, including TUBG2, assemble with specific gamma-tubulin complex proteins (GCPs) to form the γ-tubulin ring complex (γ-TuRC), which templates and organizes microtubule growth critical for mitosis, cell cycle progression, and spatial organization of the cytoskeleton[1][2][3]. While γ-tubulins are central structural proteins, they are not classical therapeutic targets (receptors/enzymes) and are not currently directly drugged in clinical practice. Their function is most notable in centrosomal and spindle pole body microtubule nucleation, and emerging research links γ-tubulin roles to cancer biology, genome stability, and possibly DNA repair[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin gamma-2 chain (TUBG2).